Because lncRNAs occupy a large part of the human genome in comparison to protein-coding genes, increasing evidence suggests that disease-suspected loci based on LD and GWAS are in the loci with lncRNAs [12,13], including the well-known example of the lncRNA, ANRIL [official gene symbol: CDKN2B-AS1 (CDKN2B antisense RNA 1)], which corresponds to the Chr9p21 risk locus for coronary artery disease based on GWAS studies [14,15,16,17,18,19,20,21]. This evidence concerns the gene CDKN2B-AS1 and coronary artery disorder.